U.S. FDA Grants Lipogems(R) Second IDE Approval for a Clinical Trial on the Treatment for Knee OA
ATLANTA, Oct. 4, 2023 -- (Healthcare Sales & Marketing Network) -- The U. S. Food and Drug Administration (FDA) has awarded Lipogems another Investigational Device Exemption (IDE) study for the use of MicroFat for the treatment of knee osteoarthritis (OA)... Devices, Orthopaedic, FDA Lipogems, MicroFat, knee osteoarthritis, osteoarthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 4, 2023 Category: Pharmaceuticals Source Type: news
Rarebase Names Chris Moxham as Chief Executive Officer
Onno Faber Becomes Company's First Chief Technology Officer
PALO ALTO, Calif., Oct. 4, 2023 -- (Healthcare Sales & Marketing Network) -- Rarebase, a platform drug development biotechnology company that is revolutionizing discovering and developing medi... Biopharmaceuticals, Personnel Rarebase, rare diseases, drug-gene atlas (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 4, 2023 Category: Pharmaceuticals Source Type: news
Amber Implants Announces Start of Clinical Trial with VCFix(R) Spinal System
Pioneering Safer and More Effective Solutions for Vertebral Fractures
THE HAGUE, Netherlands, Oct. 3, 2023 -- (Healthcare Sales & Marketing Network) -- Amber Implants, an innovative medical technology company developing next-generation implants for spi... Devices, Neurosurgery, Orthopaedic Amber Implants, VCFix Spinal System, vertebral compression fractures (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 3, 2023 Category: Pharmaceuticals Source Type: news
MedAlliance Acquired by Cordis for up to USD 1.135 Billion
GENEVA, Switzerland, Oct. 2, 2023 -- (Healthcare Sales & Marketing Network) -- Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of $35M and a 2023 upfront closing payment of $200M, together with regulato... Devices, Interventional, Cardiology, Mergers & Acquisitions MedAlliance, Cordis, SELUTION SLR, drug-eluting balloon (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 2, 2023 Category: Pharmaceuticals Source Type: news
nRichDX Launches New CTC Enrichment Kit
The Revolution CTC Enrichment Kit (Epithelial Cell Origin) is nRichDX's latest product to advance liquid biopsy development
IRVINE, Calif., Sept. 29, 2023 -- (Healthcare Sales & Marketing Network) -- nRichDX® has launched its new RUO-labeled CTC e... Diagnostics, Oncology, Product Launch nRichDX, CTC Enrichment Kit, Circulating Tumor Cells, liquid biopsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 29, 2023 Category: Pharmaceuticals Source Type: news
Cardinal Health Launches Kangaroo OMNI(TM) Enteral Feeding Pump
The next generation in enteral feeding, Kangaroo OMNI delivers nutrition and hydration from hospital to home
DUBLIN, Ohio, Sept. 28, 2023 -- (Healthcare Sales & Marketing Network) -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its K... Devices, Product Launch Cardinal Health, Kangaroo OMNI, Enteral Feeding Pump (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 28, 2023 Category: Pharmaceuticals Source Type: news
2,500 Procedures Completed in U.S. with Centinel Spine's prodisc(R) C Vivo and prodisc C SK Cervical Total Disc Replacement System, Less than One Year After Limited Launch
Centinel Spine exceeds 2,500 U.S. procedures after limited release of prodisc C Vivo in September 2022 and prodisc C SK in October 2022.
The 2,500 procedure milestone was achieved rapidly after surpassing 1,000 procedures in April 2023.
Centinel Spin... Devices, Neurosurgery, Orthopaedic Centinel Spine, total disc replacement, prodisc , spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 28, 2023 Category: Pharmaceuticals Source Type: news
Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer
Medical device industry veteran, Jon Hunt, will lead the next phase of growth for Implicity as demand for remote cardiac monitoring and data management solutions soars
CAMBRIDGE, Mass., Sept. 27, 2023 -- (Healthcare Sales & Marketing Network) -- Implic... Devices, Cardiology, Monitoring, Personnel Implicity, remote cardiac monitoring (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 27, 2023 Category: Pharmaceuticals Source Type: news
Gensco(R) Pharma Announces RizaFilm(R) Commercialization Update in the United States
MIAMI, Sept. 26, 2023 -- (Healthcare Sales & Marketing Network) -- Gensco® Pharma, a specialty pharmaceutical company, in partnership with IntelGenx is announcing the anticipated launch of RizaFilm® for Q1-2024. RizaFilm® is based on IntelGenx... Biopharmaceuticals, Drug Delivery, Product Launch Gensco Pharma, RizaFilm, rizatriptan, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 26, 2023 Category: Pharmaceuticals Source Type: news
Abyrx Receives FDA Clearance for MONTAGE(R) Settable Bone Putty for Use in Cardiothoracic Surgery
First-Ever FDA Clearance for Use of a Settable Bone Putty on the Sternum Delivers Long-awaited Innovation for Enhancing Sternal Repair in Cardiothoracic Surgeries
STAMFORD, Conn., Sept. 26, 2023 -- (Healthcare Sales & Marketing Network) -- Abyrx, Inc. ... Devices, Surgery, FDA Abyrx , MONTAGE , Settable Bone Putty, bone void filler, moldable putty (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 26, 2023 Category: Pharmaceuticals Source Type: news
Adela Announces $48 Million in Financing and Leadership Addition to Advance Tissue-Agnostic Minimal Residual Disease (MRD) Monitoring Product Portfolio Based on Genome-Wide Methylome Approach
Investors include F-Prime Capital, OrbiMed, Deerfield Management, Decheng Capital, Labcorp and RA Capital Management
Proceeds from this financing will be used to advance Adela's technology platform and commercialize Adela's first product for MRD monitor... Diagnostics, Venture Capital Adela Inc, multi-cancer early detection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 25, 2023 Category: Pharmaceuticals Source Type: news
Abbott Completes Acquisition of Bigfoot Biomedical
ABBOTT PARK, Ill., Sept. 22, 2023 -- (Healthcare Sales & Marketing Network) -- Abbott (NYSE: ABT) today announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes.
... Devices, Endocrinology, Mergers & Acquisitions Abbott, Bigfoot Biomedical, FreeStyle Libre, continuous glucose monitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 22, 2023 Category: Pharmaceuticals Source Type: news
Tyber Medical Gains FDA and MDR Clearance for its Implantable K-Wires and Steinmann Pins in Stainless Steel and Titanium Alloy
BETHLEHEM, Pa., Sept. 21, 2023 -- (Healthcare Sales & Marketing Network) -- Tyber Medical, a leader in the medical device industry, is pleased to announce that it has received:
FDA and MDR clearance for its implantable K-Wires and Steinmann Pins made... Devices, Orthopaedic, FDA Tyber Medical, K-Wire, Steinmann Pin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 21, 2023 Category: Pharmaceuticals Source Type: news
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
The company's newest Simplera CGM is 50% smaller than its previous generation with a simple insertion and improved user experience
DUBLIN, Sept. 21, 2023 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), a global leader in healthc... Devices, Endocrinology, Regulatory Medtronic, Simplera , continuous glucose monitor, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 21, 2023 Category: Pharmaceuticals Source Type: news
VerImmune Inc. announces over $3M Additional Funding
Funding follows VerImmune's successful FDA pre-IND meeting as well as completion of a key process development milestone.
Participation occurred from existing investors as well as a pharmaceutical partner.
Proceeds will be used to accelerate GLP/GMP ... Biopharmaceuticals, Oncology, Venture Capital VerImmune, Anti-tumor Immune Redirection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 20, 2023 Category: Pharmaceuticals Source Type: news
